Form 4: Allovir Inc. Chief Accounting Officer Sells Shares to Cover Tax Obligations

Allovir Inc.'s Chief Accounting Officer, Brett R. Hagen, sold 554 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., sold 554 shares of common stock on November 19, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $0.5485, with individual transactions ranging from $0.545 to $0.572.
• Following the transaction, Mr. Hagen directly owns 68,506 shares of Allovir common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to equity compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The sale of 554 shares is a relatively small transaction and is unlikely to have a significant impact on the overall market for Allovir stock.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is unlikely to be significant.

Key Dates

Keywords

Allovir, stock sale, insider trading, Form 4, Brett Hagen, tax obligations, restricted stock units, ALVR, Chief Accounting Officer